Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common Stock - $0.01 Par Value
-
Shares outstanding
-
46,444,122
-
Total 13F shares
-
45,113,689
-
Share change
-
+1,103,232
-
Total reported value
-
$1,925,520,203
-
Put/Call ratio
-
43%
-
Price per share
-
$42.68
-
Number of holders
-
296
-
Value change
-
+$46,047,746
-
Number of buys
-
108
-
Number of sells
-
124
Institutional Holders of AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value (AVNS) as of Q1 2019
As of 31 Mar 2019,
AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value (AVNS) was held by
296 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
45,113,689 shares.
The largest 10 holders included
BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, Champlain Investment Partners, LLC, DIMENSIONAL FUND ADVISORS LP, VICTORY CAPITAL MANAGEMENT INC, STATE STREET CORP, Paradice Investment Management LLC, WELLINGTON MANAGEMENT GROUP LLP, and GOLDMAN SACHS GROUP INC.
This page lists
296
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.